Seminars in Liver Disease

LinksSchließen

Referenz

Simon TG, Bonilla H, Yan P, Chung RT, Butt AA.
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: results from ERCHIVES.

Hepatology 2016;
64 (01) 47-57

Bibliographische Angaben herunterladen

Aufrufen in: